{"transactions":[{"id":3525817,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-09-08T20:30:03.000Z","date":"2026-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":460,"price":9.05,"value":4163.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":59465,"source":{"system":"sec-edgar","filing":"0001193125-26-385250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526385250/ownership.xml","form_type":"4"}},{"id":708267,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-16T20:30:48.000Z","date":"2026-07-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1555,"price":11.035,"value":17159.425,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":59925,"source":{"system":"sec-edgar","filing":"0001193125-26-306165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526306165/ownership.xml","form_type":"4"}},{"id":869119,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-03T22:11:25.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":414,"price":12.56,"value":5199.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares underlying RSUs that were surrendered by the reporting person to the Issuer upon vesting of such RSU in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":61480,"source":{"system":"sec-edgar","filing":"0001193125-26-088730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526088730/ownership.xml","form_type":"4"}},{"id":869118,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-03T22:11:25.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":964,"price":12.56,"value":12107.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares underlying the performance stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":61894,"source":{"system":"sec-edgar","filing":"0001193125-26-088730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526088730/ownership.xml","form_type":"4"}},{"id":869117,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-03T22:11:25.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":2790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares issued upon vesting of performance stock units granted to the reporting person on February 27, 2025 based on the achievement of performance criteria determined to be satisfied on February 27, 2026."}],"balance_after":62858,"source":{"system":"sec-edgar","filing":"0001193125-26-088730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526088730/ownership.xml","form_type":"4"}},{"id":869116,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-03T22:11:25.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on February 27, 2026. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of February 27, 2026, the vesting commencement date, subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":60068,"source":{"system":"sec-edgar","filing":"0001193125-26-088730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526088730/ownership.xml","form_type":"4"}},{"id":932543,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:42:13.000Z","date":"2026-01-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":776,"price":13.61,"value":10561.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":47068,"source":{"system":"sec-edgar","filing":"0001193125-26-021164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526021164/ownership.xml","form_type":"4"}},{"id":962279,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-12-19T22:50:58.000Z","date":"2025-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":230,"price":16.28,"value":3744.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":47844,"source":{"system":"sec-edgar","filing":"0001193125-25-327135","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312525327135/ownership.xml","form_type":"4"}},{"id":1006975,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-05T21:30:03.000Z","date":"2025-11-03","kind":"sale","planned":false,"acquired":false,"shares":524,"price":13.51,"value":7079.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."}],"balance_after":47407,"source":{"system":"sec-edgar","filing":"0001193125-25-267057","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312525267057/ownership.xml","form_type":"4"}},{"id":1045014,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-09-09T20:40:19.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":461,"price":12.09,"value":5573.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."}],"balance_after":47931,"source":{"system":"sec-edgar","filing":"0000950170-25-113822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000095017025113822/ownership.xml","form_type":"4"}},{"id":1084818,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-07-18T20:05:07.000Z","date":"2025-07-16","kind":"sale","planned":false,"acquired":false,"shares":1692,"price":8.3639,"value":14151.7188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in mutliple transactions at prices $8.364 and $8.35. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":48392,"source":{"system":"sec-edgar","filing":"0000950170-25-096917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000095017025096917/ownership.xml","form_type":"4"}},{"id":1139255,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-21T21:17:36.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest with respect to 25% of the shares of common stock on May 19, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates."}],"balance_after":33000,"derivative":{"exercise_price":4.39,"expiration_date":"2035-05-18","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0000950170-25-075870","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000095017025075870/ownership.xml","form_type":"4"}}]}